Busulfan and Hepatomegaly - a phase IV clinical study of FDA data

Summary:

Hepatomegaly is reported as a side effect among people who take Busulfan (busulfan), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Hepatomegaly when taking Busulfan. It is created by eHealthMe based on reports of 14,527 people who have side effects when taking Busulfan from the FDA, and is updated regularly.

What is Busulfan?

Busulfan has active ingredients of busulfan. eHealthMe is studying from 14,527 Busulfan users. Check the latest studies of Busulfan.

What is Hepatomegaly?

Hepatomegaly (abnormal enlargement of the liver) is found to be associated with 1,329 drugs and 1,924 conditions by eHealthMe. Check the latest studies of Hepatomegaly.

On May, 14, 2026

14,527 people reported to have side effects when taking Busulfan.
Among them, 121 people (0.83%) have Hepatomegaly.

Among these 121 people:

* Approximation only. Some reports may have incomplete information.

Do you take Busulfan and have Hepatomegaly?

- Check whether Hepatomegaly is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Busulfan:

Busulfan (14,527 reports)

Hepatomegaly treatments and more:

Hepatomegaly (20,071 reports)

How severe was Hepatomegaly and when was it recovered:

Hepatomegaly in Busulfan

Expand to all the drugs that have ingredients of busulfan:

Hepatomegaly and drugs with ingredients of busulfan

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Busulfan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatomegaly:

Hepatomegaly (1,329 drugs)

Browse all the conditions that are associated with Hepatomegaly:

Hepatomegaly (1,924 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on busulfan (the active ingredients of Busulfan) and Busulfan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.